United States· US:49281-645_775d34bb-508b-47ef-af40-d4dbf8ea132c
FLUZONE TRIVALENT NORTHERN HEMISPHERE
A medicinal product containing influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated), registered in United States by Sanofi Vaccines US Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Manufacturer
- Sanofi Vaccines US Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1149281-645-15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d98a2426-617d-4ac4-9003-56c5f25b3490 GET /v1/drugs/d98a2426-617d-4ac4-9003-56c5f25b3490?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR",
"source": "ndc",
"strength": "15; 15; 15",
"substance": "INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"productndc": "49281-645",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "ug/.5mL; ug/.5mL; ug/.5mL",
"application_number": "BLA103914",
"marketing_category": "BLA"
}See everything about influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.